Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ITMCTR2026000416) titled 'Clinical and Basic Research on Yishen Huashi Granules in the Treatment of Diabetic Nephropathy' on Feb. 25.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Second Hospital of Lanzhou University
Condition:
Diabetic Nephropathy
Intervention:
Experimental Group:On the basis of adequate-dose application of RAS inhibitors, take Yishen Huashi Keli (Kidney-Nourishing and Dampness-Resolving Granules), 10g per sachet, 3 times a day, 1 sachet each time. Dissolve in boiling water for oral administration, and continue taking for 6 months.
Recruitment Status: Recruiting
Phase: Post-marketin...